Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Preventive Medicine
- Tobacco companies introduce ‘tobacco-free’ nicotine pouches.Tob Control. 2020; 29: e145-e146https://doi.org/10.1136/tobaccocontrol-2019-055321
Deeming tobacco products to be subject to the federal food, drug, and cosmetic act, as amended by the family smoking prevention and tobacco control act. HHS, Food and Drug Administration. https://www.fda.gov/tobacco-products/rules-regulations-and-guidance/fdas-deeming-regulations-e-cigarettes-cigars-and-all-other-tobacco-products. Updated September 1, 2021. Accessed May 3, 2022.
New law clarifies FDA authority to regulate synthetic nicotine. U.S. Food and Drug Administration. https://content.govdelivery.com/accounts/USFDA/bulletins/30f82ff. Updated March 18, 2022. Accessed April 11, 2022.
Czaplicki L, Patel M, Rahman B, Yoon S, Schillo B, Rose SW. Oral nicotine marketing claims in direct-mail advertising. Tob Control. In press, Online, 6, May, 2021. https://doi.org/10.1136/tobaccocontrol-2020-056446.
- Pharmacokinetic comparison of a novel non-tobacco-based nicotine pouch (ZYN) with conventional, tobacco-based Swedish snus and American moist snuff.Nicotine Tob Res. 2020; 22: 1757-1763https://doi.org/10.1093/ntr/ntaa068
- Characterization of the abuse potential in adult smokers of a novel oral tobacco product relative to combustible cigarettes and nicotine polacrilex gum.Clin Pharmacol Drug Dev. 2021; 10: 241-250https://doi.org/10.1002/cpdd.909
- Nicotine pharmacokinetics and subjective response among adult smokers using different flavors on!® nicotine pouches compared to combustible cigarettes.Psychopharmacology (Berl). 2021; 238: 3325-3334https://doi.org/10.1007/s00213-021-05948-y
- A randomised study to investigate the nicotine pharmacokinetics of oral nicotine pouches and a combustible cigarette.Eur J Drug Metab Pharmacokinet. 2022; 47: 211-221https://doi.org/10.1007/s13318-021-00742-9
- Chemical characterization of tobacco-free “modern” oral nicotine pouches and their position on the toxicant and risk continuums.Drug Chem Toxicol. 2021; (In press. Online May 25)https://doi.org/10.1080/01480545.2021.1925691
- Examining market trends in smokeless tobacco sales in the United States: 2011-2019.Nicotine Tob Res. 2021; 23: 1420-1424https://doi.org/10.1093/ntr/ntaa239
- Nicotine pouch unit sales in the U.S., 2016-2020.JAMA. 2021; 326: 566-568https://doi.org/10.1001/jama.2021.10366
- Patterns of non-cigarette tobacco and nicotine use among current cigarette smokers and recent quitters: findings from the 2020 ITC Four Country Smoking and Vaping Survey.Nicotine Tob Res. 2021; 23: 1611-1616https://doi.org/10.1093/ntr/ntab040
- Heated tobacco products and nicotine pouches: a survey of people with experience of smoking and/or vaping in the UK.Int J Environ Res Public Health. 2021; 18: 8852https://doi.org/10.3390/ijerph18168852
- Initial information on a novel nicotine product.Am J Addict. 2020; 29: 279-286https://doi.org/10.1111/ajad.13020
ITC Project. (2021, July). ITC Four Country Smoking and Vaping Survey, Wave 3 (4CV3, 2020) Technical Report. University of Waterloo, Waterloo, Ontario, Canada; Medical University of South Carolina, Charleston, South Carolina, United States; Cancer Council Victoria, Melbourne, Australia; the University of Queensland, Australia; King’s College London, London, United Kingdom; 2020 (4CV3; 2020) [Preliminary Technical Report].
- The conceptual framework of the International Tobacco Control (ITC) Policy Evaluation Project.Tob Control. 2006; 15: iii3-iii11https://doi.org/10.1136/tc.2005.015438
- Methods of the ITC Four Country Smoking and Vaping Surveysurvey, Wave 1 (2016).Addiction. 2019; 114: 6-14https://doi.org/10.1111/add.14528
Hrywna M, Gonsalves NJ, Delnevo CD, Wackowski OA. Nicotine pouch product awareness, interest and ever use among U.S. adults who smoke, 2021. Tob Control. In press. Online February 25, 2022. https://doi.org/10.1136/tobaccocontrol-2021-057156.
- Awareness, use and perceptions of cigarillos, heated tobacco products and nicotine pouches: a survey among Dutch adolescents and adults.Drug Alcohol Depend. 2021; 229109136https://doi.org/10.1016/j.drugalcdep.2021.109136
- Tobacco product use among adults - United States, 2019.MMWR Morb Mortal Wkly Rep. 2020; 69: 1736-1742https://doi.org/10.15585/mmwr.mm6946a4
- Patterns of use of smokeless tobacco in U.S. adults, 2013–2014.Am J Public Health. 2017; 107: 1508-1514https://doi.org/10.2105/AJPH.2017.303921
- Trends in beliefs about the harmfulness and use of stop-smoking medications and smokeless tobacco products among cigarettes smokers: findings from the ITC four-country survey.Harm Reduct J. 2011; 8: 21https://doi.org/10.1186/1477-7517-8-21
- Smoker awareness of and beliefs about supposedly less-harmful tobacco products.Am J Prev Med. 2005; 29: 85-90https://doi.org/10.1016/j.amepre.2005.04.013
- Longitudinal transitions of exclusive and polytobacco electronic nicotine delivery systems (ENDS) use among youth, young adults and adults in the USA: findings from the PATH Study Waves 1–3 (2013–2016).Tob Control. 2020; 29: s147-s154https://doi.org/10.1136/tobaccocontrol-2019-055574
- Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching.Tob Control. 2016; 25: 267-274https://doi.org/10.1136/tobaccocontrol-2014-052080
- Snus use and rejection in the USA.Tob Control. 2016; 25: 386-392https://doi.org/10.1136/tobaccocontrol-2013-051342
- A longitudinal, naturalistic study of U.S. smokers’ trial and adoption of snus.Addict Behav. 2016; 63: 82-88https://doi.org/10.1016/j.addbeh.2016.07.008
- Snus undermines quit attempts but not abstinence: a randomised clinical trial among U.S. smokers.Tob Control. 2017; 26: 202-209https://doi.org/10.1136/tobaccocontrol-2015-052783
- Smokeless and flavored tobacco products in the U.S.: 2009 Styles survey results.Am J Prev Med. 2012; 42: 29-36https://doi.org/10.1016/j.amepre.2011.08.019